Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential

1,25-Dihydroxyvitamin D 3 (1,25D) regulates gene transcription through a nuclear vitamin D receptor (VDR) which acts as a ligand-regulated transcription factor. Some structural vitamin D analogs (VDAs) are selective in their biological actions, because they retain cell-differentiating potential, whi...

Full description

Saved in:
Bibliographic Details
Published inSteroids Vol. 73; no. 14; pp. 1359 - 1366
Main Authors Gocek, Elżbieta, Kiełbiński, Marek, Wyłób, Paulina, Kutner, Andrzej, Marcinkowska, Ewa
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Inc 22.12.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:1,25-Dihydroxyvitamin D 3 (1,25D) regulates gene transcription through a nuclear vitamin D receptor (VDR) which acts as a ligand-regulated transcription factor. Some structural vitamin D analogs (VDAs) are selective in their biological actions, because they retain cell-differentiating potential, while their calcemic activity is reduced. In this article we have shown that in untreated HL60 cells the expression level of VDR is low, in spite of constant presence of VDR mRNA. Furthermore we have shown that one of the most rapid effects of either 1,25D or VDAs is nuclear accumulation of VDR, which is proportional to the differentiation-inducing potential of given analog. We observed this effect not only in HL60 cells, but also in blast cells isolated from patients with acute myeloid leukemias. After longer incubation time of the cells with various VDAs, the expression levels of VDR have become unrelated to the final differentiation effect.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0039-128X
1878-5867
DOI:10.1016/j.steroids.2008.06.010